Steven Horwitz, MD
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Steven Horwitz, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:08 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06698003 · A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1Memorial Sloan Kettering Cancer Center · recruiting · T-Cell Leukemia/Lymphoma, Adult, T-cell Leukemia/Lymphoma, T-cell Leukemia · principal investigator
- N/ANCT05978141 · A Registry for People With T-cell LymphomaMemorial Sloan Kettering Cancer Center · recruiting · T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia · principal investigator
- Ph2NCT04101331 · Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis FungoidesAffimed GmbH · completed · Peripheral T Cell Lymphoma, Transformed Mycosis Fungoides · principal investigator
- N/ANCT03964480 · Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.Associazione Angela Serra per la ricerca sul cancro · recruiting · Peripheral T-Cell Lymphoma · principal investigator
- Ph1NCT02783625 · Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell LymphomasMemorial Sloan Kettering Cancer Center · completed · Lymphoma, Relapsed/Refractory T-cell Lymphomas · principal investigator
- Ph1/Ph2NCT02341014 · Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell LymphomasMemorial Sloan Kettering Cancer Center · completed · T-cell Lymphomas, Relapsed or Refractory · principal investigator
- Ph1/Ph2NCT01755975 · Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and MyelomaMemorial Sloan Kettering Cancer Center · completed · Multiple Myeloma, Non-Hodgkin's Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:08 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.